A critical advance in cancer investigation is occurring with the use of VHH fragments to re-engage mutated p53. This essential tumor inhibitor protein is frequently disabled in various kinds of cancer, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research